Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Ovarian Cancer × stenoparib × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Ovarian Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Advanced Ovarian Cancer 1

Interventions

Saline Solution 3 Bevacizumab 2 talazoparib 1 stenoparib 1 senaparib 1 sargramostim 1 niraparib 1 Tranexamic Acid 1 Ropivacaine 1 Paclitaxel 1 Observation 1 Hyperthermic Intraperitoneal Chemotherapy 1 Carboplatin 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03878849 2025-08-28

Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer

Allarity Therapeutics

Phase 2 Recruiting

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡